Journal Guide

Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

Current Nanoscience publishes (a) Authoritative/Mini Reviews, and (b) Original Research and Highlights written by experts covering the most recent advances in nanoscience and nanotechnology. All aspects of the field are represented including nano-structures, nano-bubbles, nano-droplets and nanofluids. Applications of nanoscience in physics, material science, chemistry, synthesis, environmental science, electronics, biomedical nanotechnology, biomedical engineering, biotechnology, medicine and pharmaceuticals are also covered. The journal is essential to all researches involved in nanoscience and its applied and fundamental areas of science, chemistry, physics, material science, engineering and medicine.

The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In Current Opinion in Biotechnology, we help the reader by providing in a systematic manner:1. The views of experts on current advances in biotechnology in a clear and readable form.2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Division of the subject into sectionsThe subject of biotechnology is divided into themed sections, each of which is reviewed once a year. The amount of space devoted to each section is related to its importance.Analytical biotechnology • Plant biotechnology • Food biotechnology • Energy biotechnology • Environmental biotechnology • Systems biology • Nanobiotechnology • Tissue, cell and pathway engineering • Chemical biotechnology • Pharmaceutical biotechnologySelection of topics to be reviewedSection Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.ReviewsAuthors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.Editorial OverviewSection Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Biotechnology one of the most highly regarded and highly cited review journals in the field (Impact factor = 7.711).Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest

Current Opinion in Cell Biology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Cell Biology we help the reader by providing in a systematic manner:1. The views of experts on current advances in their field in a clear and readable form.2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publicationsCurrent Opinion in Cell Biology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Division of the subject into sectionsThe subject of Cell Biology is divided into seven themed sections, each of which is reviewed once a year.• Cell structure and dynamics• Cell regulation• Nucleus and gene expression• Membranes and organelles• Cell-to-cell contact and extracellular matrix• Cell differentiation• Cell division, growth and deathSelection of topics to be reviewedSection Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. The Editorial Board provides support to the Editors and the Section Editors with their comments and suggestions on names and topics.Review articles in Current Opinion in Cell Biology are by invitation only.Review ArticlesAuthors write short review articles in which they present recent developments in their subject, emphasizing the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous two years.Editorial OverviewSection Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Cell Biology one of the most highly regarded and highly cited review journals in the field (Impact factor = 14.153)

The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In Current Opinion in Chemical Biology, we help the reader by providing in a systematic manner:1. The views of experts on current advances in chemical biology in a clear and readable form.2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Division of the subject into sections:The subject of chemical biology is divided into themed sections which are reviewed regularly to keep them relevant. For 2014 they are:• Arrays • Bioinorganic chemistry • Biocatalysis and Biotransformation • Molecular Imaging • In Vivo Chemistry • Mechanisms • Synthetic Biology • Synthetic Biomolecules • Molecular ImmunologySelection of topics to be reviewed:Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.Reviews:Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.Editorial Overview:Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Chemical Biology one of the most highly regarded and highly cited review journals in the field.Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest

This reader-friendly resource provides a powerful, broad-based perspective on the most important advances from throughout the world literature. Featuring renowned guest editors and focusing exclusively on one or two topics, every issue of Current Opinion in Endocrinology, Diabetes and Obesity delivers unvarnished, expert assessments of developments from the previous year. All reviews are supplemented with an indispensable section,References and Recommended Reading. At the back of each volume is Current World Literature, an exceptionally thorough bibliography culled from hundreds of top journals in the field.Website:www.co-endocrinology.com.

Current Opinion in Genetics and Development aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Genetics and Development we help the reader by providing in a systematic manner:1. The views of experts on current advances in their field in a clear and readable form.2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publicationsCurrent Opinion in Genetics and Development will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Division of the subject into sectionsThe subject of Genetics and Development is divided into six themed sections, each of which is reviewed once a year.• Genetic and cellular mechanisms of oncogenesis• Chromosomes, genomes and expression mechanisms• Molecular and genetic bases of disease• Developmental mechanisms, patterning and evolution• Differentiation and gene regulation• Genetics of system biologySelection of topics to be reviewedSection Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. The Editorial Board provides support to the Editors and the Section Editors with their comments and suggestions on names and topics.Review articles in Current Opinion in Genetics and Development are by invitation only.Review ArticlesAuthors write short review articles in which they present recent developments in their subject, emphasizing the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous two years.Editorial OverviewSection Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Genetics and Development one of the most highly regarded and highly cited review journals in the field (Impact factor = 8.987).

American Heart Association members are eligible for a 20% discount on subscription rates.This reader-friendly, bimonthly resource provides a powerful, broad-based perspective on the most important advances from throughout the world literature. Featuring renowned guest editors and focusing exclusively on one topic, every issue of Current Opinion in Lipidology delivers unvarnished, expert assessments of developments from the previous year. All reviews are supplemented with an indispensable section, 'References and Recommended Reading'. At the back of each volume is 'Current World Literature', an exceptionally thorough bibliography culled from the top 100 journals in the field.Website: www.co-lipidology.com.

Current Opinion in Oncology Online provides a powerful, broad-based perspective on the most important advances in the field from throughout the world literature. Reader-friendly, the journal features renowned guest editors focusing exclusively on two topics each issue. Bimonthly, every issue of Current Opinion in Oncology delivers unvarnished, expert assessments of developments from the previous year. Insightful editorials and on-the-mark invited reviews cover key subjects such as endocrine tumors; melanoma and other skin neoplasms; the genitourinary system; supportive care; cancer in AIDS; and the breast--some 18 or more items in all of major relevance. All reviews are supplemented with an indispensable section, 'References and Recommended Reading'. At the back of each volume is 'Current World Literature', an exceptionally thorough bibliography culled from the top 100 journals in the field.Website: www.co-oncology.com.

Current Opinion in Structural Biology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Structural Biology we help the reader by providing in a systematic manner:1. The views of experts on current advances in their field in a clear and readable form.2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Current Opinion in Structural Biology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Division of the subject into sectionsThe subject of Structural Biology is divided into twelve themed sections, each of which is reviewed once a year. Each issue contains two sections, and the amount of space devoted to each section is related to its importance.Folding and BindingNucleic acids and their protein complexesMacromolecular MachinesTheory and SimulationSequences and TopologyNew constructs and expression of proteinsMembranesEngineering and DesignCarbohydrate-protein interactions and glycosylationBiophysical and molecular biological methodsMulti-protein assemblies in signallingCatalysis and RegulationSelection of topics to be reviewedSection Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. The Editorial Board provides support to the Editors and the Section Editors with their comments and suggestions on names and topics.Review articles in Current Opinion in Structural Biology are by invitation only.Review ArticlesAuthors write short review articles in which they present recent developments in their subject, emphasizing the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous two years.Editorial OverviewSection Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Structural Biology one of the most highly regarded review journals in the field with an Impact factor of 9.344.

Current Organic Synthesis publishes in-depth reviews, original research articles and letter/short communications on all areas of synthetic organic chemistry i.e. asymmetric synthesis, organometallic chemistry, novel synthetic approaches to complex organic molecules, carbohydrates, polymers, protein chemistry, DNA chemistry, supramolecular chemistry, molecular recognition and new synthetic methods in organic chemistry. The frontier reviews provide the current state of knowledge in these fields and are written by experts who are internationally known for their eminent research contributions. The journal is essential reading to all synthetic organic chemists. Current Organic Synthesis should prove to be of great interest to synthetic chemists in academia and industry who wish to keep abreast with recent developments in key fields of organic synthesis.

Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews, research articles and letters written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Current Pharmacogenomics and Personalized Medicine (CPPM) is a transdisciplinary peer-reviewed biomedical journal that reports new findings and cutting-edge concepts in both pharmacogenomics and personalized medicine under a single cover. CPPM is an accelerator for global personalized medicine and pharmacogenomics. Importantly, the journal provides a multi-disciplinary integrated platform from cell to society to address diagnostics and responsible pharmacogenomics applications in developing countries.

Fundamental plant sciences is increasingly becoming a collaborative domain, with projects for example including physics, mathematics and chemistry. This is largely fuelled by the last decade's many technical advances, allowing for more discoveries but also creating new challenges, such as data storage, analysis and predictions. Interdisciplinary collaborations are often the solution to these challenges.

This journal aims to acknowledge and encourage interdisciplinary research in fundamental plant sciences. It will publish original research papers and method papers in plant research fields such as systems biology, cell biology, genetics, epigenetics, mathematical modeling, omics, signal transduction, plant-microbe interactions, synthetic biology, developmental biology, biochemistry, bioinformatics research, and big data in plant biology. High-quality review articles are also welcome.

To further encourage collaboration in the community, all accepted authors of Research articles are required to make their data accessible to the public. This will avoid duplicate projects and speed up the progress of science. The journal will actively link and cooperate with some of these databases, as well as with computational infrastructure. Data should always be submitted in raw data format, and should be submitted preferentially in publicly accessible resources maintained by for example EBI, EMBL, or NCBI data. Which data repository is used is up to the authors, however please visit http://www.elsevier.com/databaselinking for more information on depositing and linking your data with a supported data repository. For datatypes for which no such repositories exist, data should be made available through the supplementary information or the authors own website. If the data has been processed into e.g. pathways or models, then this should be made available also during the review process.

For more submission information, see our Guide for Authors.

The editorial and publishing team of the journal is dedicated to being efficient in the manuscript handling. The journal uses a double-blinded peer review, to avoid bias in the review process. The resulting publications will be open access.

Each bimonthly issue of Current Problems in Cancer presents a single-topic, in-depth discussion, usually focused on the integrated management of a particular type of cancer or on a problem faced in a wide variety of malignancies. Issues may explore a particular category of drugs, an emerging interventional technique, or rehabilitation/reconstruction. Extensive bibliographies allow readers to easily locate additional information on related topics. Current Problems in Cancer serves the wide spectrum of physicians who treat patients with neoplastic disease.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.If you require any further information or help, please visit our support pages: http://support.elsevier.com